In vitro activity of cefiderocol against Gram-negative pathogens isolated from people with cystic fibrosis and bronchiectasis

In vitro activity of cefiderocol against Gram-negative pathogens isolated from people with cystic fibrosis and bronchiectasis

ABSTRACT: Objectives: Gram-negative pathogens causing respiratory infection in people with cystic fibrosis and bronchiectasis are becoming progressively more resistant to conventional antibiotics. Although cefiderocol is licenced for the treatment of infections due to Gram-negative organisms, there...

Full description

Bibliographic Details
Main Authors: Michael M Tunney, J Stuart Elborn, Chloe S McLaughlin, Christopher M Longshaw
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Cefiderocol
Cystic fibrosis
Stenotrophomonas maltophilia
Achromobacter
Burkholderia cepacia complex
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716524000298

Internet

http://www.sciencedirect.com/science/article/pii/S2213716524000298

Similar Items